Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  DesRochers, Teresa M ^a   Suter, Laura ^b   Roth, Adrian ^b   Kaplan, David L ^a  

^a Tufts University   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CISPLATIN; DOXORUBICIN; GENTAMICIN; KIDNEY INJURY MOLECULAR 1; LACTATE DEHYDROGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ARTICLE; BIOENGINEERING; CELL FUNCTION; CELL IMMORTALIZATION; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; LD 50; MOLECULAR DYNAMICS; MOLECULAR IMAGING; NEPHROTOXICITY; PHENOTYPE; SENSITIVITY ANALYSIS; THREE DIMENSIONAL IMAGING; TOXICITY TESTING;

CELLS, CULTURED; CISPLATIN; DOXORUBICIN; EPITHELIAL CELLS; GENTAMICINS; HUMANS; KIDNEY; TISSUE ENGINEERING;

EID: 84875048928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059219     Document Type: Article

References (48)

1. Dimasi JA, Hansen RW, Grabowski HG, (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22: 151-85.
2. Food and Drug Administration. (2004) Innovation or Stagnation: Challenge and opportunity on the critical path to new medical products.
3. Fuchs TC, Hewitt P, (2011) Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J 13: 615-631.
4. Pannu N, Nadim MK, (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36: S216-S223.
5. Chen JC, Stevens JL, Trifillis AL, Jones TW, (1990) Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells. Toxicol Appl Pharmacol 103: 463-473.
6. Garrett SH, Somji S, Todd JH, Sens DA, (1998) Exposure of human proximal tubule cells to cd2+, zn2+, and Cu2+ induces metallothionein protein accumulation but not metallothionein isoform 2 mRNA. Environ Health Perspect 106: 587-595.
7. Harpur E, Ennulat D, Hoffman D, Betton G, Gautier JC, et al. (2011) Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat. Toxicol Sci 122: 235-252.
8. Gautier JC, Riefke B, Walter J, Kurth P, Mylecraine L, et al. (2010) Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin. Toxicol Pathol 38: 943-956.
9. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW, (2002) The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70: 537-546.
10. Guo Q, Xia B, Moshiach S, Xu C, Jiang Y, et al. (2008) The microenvironmental determinants for kidney epithelial cyst morphogenesis. Eur J Cell Biol 87: 251-266.
11. El MM, Laurent G, Mingeot-Leclercq MP, Tulkens PM, (2000) Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol Sci 56: 229-239.
12. Wu Y, Connors D, Barber L, Jayachandra S, Hanumegowda UM, et al. (2009) Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol In Vitro 23: 1170-1178.
13. Knight A, (2008) Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. Rev Recent Clin Trials 3: 89-96.
14. Sung JH, Shuler ML, (2009) A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 9: 1385-1394.
15. Chang R, Emami K, Wu H, Sun W, (2010) Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model. Biofabrication 2: 1-11.
16. Lan SF, Starly B, (2011) Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol Appl Pharmacol 256: 62-72.
17. Nakamura K, Mizutani R, Sanbe A, Enosawa S, Kasahara M, et al. (2011) Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J Biosci Bioeng 111: 78-84.
18. Canton I, Cole DM, Kemp EH, Watson PF, Chunthapong J, et al. (2010) Development of a 3D human in vitro skin co-culture model for detecting irritants in real-time. Biotechnol Bioeng 106: 794-803.
19. Hu T, Khambatta ZS, Hayden PJ, Bolmarcich J, Binder RL, et al. (2010) Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol In Vitro 24: 1450-1463.
20. Kirsch-Volders M, Decordier I, Elhajouji A, Plas G, Aardema MJ, et al. (2011) In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis 26: 177-184.
21. Presnell SC, Bruce AT, Wallace SM, Choudhury S, Genheimer CW, et al. (2011) Isolation, characterization, and expansion methods for defined primary renal cell populations from rodent, canine, and human normal and diseased kidneys. Tissue Eng Part C Methods 17: 261-273.
22. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, et al. (1994) HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57.
23. Chabardes D, Gagnan-Brunette M, Imbert-Teboul M, Gontcharevskaia O, Montegut M, et al. (1980) Adenylate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest 65: 439-448.
24. Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH, (2003) Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14: 1-10.
25. Turner RJ, Silverman M, (1977) Sugar uptake into brush border vesicles from normal human kidney. Proc Natl Acad Sci U S A 74: 2825-2829.
26. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, et al. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9: 215-236.
27. Couture L, Nash JA, Turgeon J, (2006) The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacol Rev 58: 244-258.
28. Schmitz C, Hilpert J, Jacobsen C, Boensch C, Christensen EI, et al. (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 277: 618-622.
29. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. (2010) Mechanisms of Cisplatin Nephrotoxicity. Toxins 2490-2518.
30. Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez-Hernandez FJ, (2011) An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci 119: 245-256.
31. Chatterjee K, Zhang J, Honbo N, Karliner JS, (2010) Doxorubicin cardiomyopathy. Cardiology 115: 155-162.
32. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW, (1980) Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 213: 551-556.
33. Goldstein RS, Noordewier B, Bond JT, Hook JB, Mayor GH, (1981) cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol Appl Pharmacol 60: 163-175.
34. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW, (1980) Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 213: 545-550.
35. Hoffmann D, Adler M, Vaidya VS, Rached E, Mulrane L, et al. (2010) Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci 116: 8-22.
36. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV, (2002) Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244.
37. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, et al. (2004) Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24: 307-315.
38. Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, et al. (2011) Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers 16: 553-566.
39. Li W, Lam M, Choy D, Birkeland A, Sullivan ME, et al. (2006) Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. Toxicol In Vitro 20: 669-676.
40. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
41. Cummings BS, Lasker JM, Lash LH, (2000) Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther 293: 677-685.
42. Nanus DM, Lynch SA, Rao PH, Anderson SM, Jhanwar SC, et al. (1991) Transformation of human kidney proximal tubule cells by a src-containing retrovirus. Oncogene 6: 2105-2111.
43. Wieser M, Stadler G, Jennings P, Streubel B, Pfaller W, et al. (2008) hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 295: F1365-F1375.
44. Servais H, Jossin Y, Van BF, Tulkens PM, Mingeot-Leclercq MP, (2006) Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob Agents Chemother 50: 1213-1221.
45. Weiland C, Ahr HJ, Vohr HW, Ellinger-Ziegelbauer H, (2007) Characterization of primary rat proximal tubular cells by gene expression analysis. Toxicol In Vitro 21: 466-491.
46. Rached E, Hoffmann D, Blumbach K, Weber K, Dekant W, et al. (2008) Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro. Toxicol Sci 103: 371-381.
47. Astashkina AI, Mann BK, Prestwich GD, Grainger DW, (2012) Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines. Biomaterials 33: 4712-4721.
48. Astashkina AI, Mann BK, Prestwich GD, Grainger DW, (2012) A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays. Biomaterials 33: 4700-4711.